Table 2 Basic demographic and clinical data of patients with N-BLD and N-HCC
Clinical features | N-BLD(n = 104) | N-HCC(n = 104) | OR(95%CI) | P value |
|---|---|---|---|---|
Cirrhosis, n(%) | 69 (66.35%) | 70 (67.31%) | 0.958 (0.538–1.706) | 0.883 |
CHB, n(%) | 35 (33.65%) | 27 (25.96%) | 1.447 (0.796–2.631) | 0.225 |
Age ≤ 60years, n(%) | 53 (50.96%) | 52 (50.00%) | 1.039 (0.603–1.790) | 0.890 |
Male, n(%) | 96 (92.31%) | 96 (92.31%) | 1.000 (0.361–2.733) | 1.000 |
Hepatitis B virus, n(%) | 94 (90.38%) | 92 (88.46%) | 1.226 (0.505–2.977) | 0.652 |
Child- Pugh class A, n(%) | 45 (43.27%) | 45 (43.27%) | 1.000 (0.578–1.731) | 1.000 |
Child- Pugh class B, n(%) | 53 (50.96%) | 54 (51.92%) | 0.962 (0.559–1.658) | 0.890 |
ALB < 40 g/L, n(%) | 40 (38.46%) | 69 (66.35%) | 0.317 (0.180–0.559) | 0.000 |
TBIL > 21µmol/L, n(%) | 41 (39.42%) | 30 (28.85%) | 1.605 (0.900-2.863) | 0.108 |
ALT > ULN, n(%) | 18 (17.31%) | 33 (31.73%) | 0.450 (0.234–0.867) | 0.016 |
AST > ULN, n(%) | 34 (32.69%) | 51 (49.04%) | 0.505 (0.288–0.885) | 0.016 |
ALP > ULN, n(%) | 25 (24.04%) | 42 (40.38%) | 0.467 (0.257–0.848) | 0.012 |
GGT > ULN, n(%) | 37 (35.58%) | 79 (75.96%) | 0.175 (0.096–0.319) | 0.000 |